Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy. Some are moving the system from within; others are reshaping it from the outside. All of them bring signal in a world crowded with noise.
…
continue reading
Sean Khozin Podcasts
1
Endpoints, Resistance, and the Architecture of Evidence in Immuno-Oncology
53:18
53:18
Play later
Play later
Lists
Like
Liked
53:18
In this episode of Precision Signals, Dr. Sean Khozin speaks with Dr. James Gulley, Chief of the Medical Oncology Service and Co-Director of the Center for Immuno-Oncology at the National Cancer Institute. Dr. Gulley is one of the world’s leading figures in immuno-oncology. He helped bring immune-based cancer therapies from an era of skepticism int…
…
continue reading
Dr. Michelle Longmire, physician-scientist, technologist, and CEO, cofounder of Medable; shares how early lessons in science and systems design shaped her mission to fix one of medicine’s most persistent bottlenecks: slow, fragmented, and inaccessible clinical trials. We discuss her path from autoimmune skin disease research at Stanford to building…
…
continue reading
1
AI in Oncology: Hype, Evidence, and the Threshold of Clinical Trust
52:18
52:18
Play later
Play later
Lists
Like
Liked
52:18
What does it take for AI to move from technical innovation to real-world adoption in oncology? In the first episode of Precision Signals, Dr. Sean Khozin speaks with Dr. Cora Sternberg and Dr. Olivier Elemento—two leaders at the intersection of clinical trials, precision medicine, and computational biology. Together, they unpack the central paradox…
…
continue reading
